Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials

OBJECTIVE: To identify drug classes and individual selective serotonin reuptake inhibitors (SSRIs) with high rates of remission and low risk of adverse events in the treatment of panic disorder with or without agoraphobia. DESIGN: Systematic review and network meta-analysis. DATA SOURCES: Embase, Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Chawla, Natasha, Anothaisintawee, Thunyarat, Charoenrungrueangchai, Kridsada, Thaipisuttikul, Papan, McKay, Gareth J, Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767458/
https://www.ncbi.nlm.nih.gov/pubmed/35045991
http://dx.doi.org/10.1136/bmj-2021-066084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767458/
https://www.ncbi.nlm.nih.gov/pubmed/35045991
http://dx.doi.org/10.1136/bmj-2021-066084

Ejemplares similares